Related Experiment Video

Updated: Jun 21, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5

Wenbin Xiao1, Hong Hong, Yuko Kawakami

  • 1Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.

Cancer Cell
|August 4, 2009
PubMed

Insights

Phospholipase C (PLC) beta3 deficiency promotes cancer by increasing hematopoietic stem cells. This suggests PLC-beta3 acts as a tumor suppressor, highlighting its role in regulating cell growth and preventing malignancies.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Phospholipase C (PLC) enzymes, including PLC-beta3, are known for their roles in cell signaling pathways that regulate cell growth.
  • Previous understanding implicated PLC in promoting cell growth, but its role in cancer development was less clear.

Purpose of the Study:

  • To investigate the in vivo function of PLC-beta3 in the context of cell proliferation and tumor development.
  • To elucidate the molecular mechanisms underlying the observed phenotypes in PLC-beta3-deficient models.

Main Methods:

  • Generation and analysis of PLC-beta3-deficient mice.
  • Hematopoietic stem cell isolation and functional assays (proliferation, survival, differentiation).
  • Investigation of signaling pathways involving Stat5 and SHP-1.
  • Analysis of tumor development in genetically modified mouse models and human cancer cell lines.

Main Results:

  • PLC-beta3-deficient mice spontaneously develop myeloproliferative disease, lymphoma, and other tumors.
  • Increased numbers of hematopoietic stem cells with enhanced proliferative, survival, and myeloid-differentiative capacities were observed in mutant mice.
  • These stem cell properties are dependent on Stat5 signaling and can be inhibited by the protein phosphatase SHP-1.
  • Cooperative transformation by c-Myc and PLC-beta3 deficiency was observed in mouse lymphomas and human Burkitt's lymphoma cells, suggesting a conserved mechanism.

Conclusions:

  • PLC-beta3 deficiency promotes malignant transformation and tumor development.
  • PLC-beta3 functions as a tumor suppressor, counteracting the oncogenic potential of Stat5 and c-Myc.
  • The findings suggest a similar mechanism operates in other human lymphoid and myeloid malignancies, positioning PLC-beta3 as a potential therapeutic target.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...